Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

MMR vaccine and idiopathic thrombocytopaenic purpura.

Black C, Kaye JA, Jick H.

Br J Clin Pharmacol. 2003 Jan;55(1):107-11.

PMID:
12534647
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy.

Bertuola F, Morando C, Menniti-Ippolito F, Da Cas R, Capuano A, Perilongo G, Da Dalt L.

Drug Saf. 2010 Jan 1;33(1):65-72. doi: 10.2165/11530350-000000000-00000.

PMID:
20000868
[PubMed - indexed for MEDLINE]
3.

Vaccination associated thrombocytopenic purpura in children.

Rajantie J, Zeller B, Treutiger I, Rosthöj S; NOPHO ITP working group and five national study groups.

Vaccine. 2007 Feb 26;25(10):1838-40. Epub 2006 Nov 9.

PMID:
17126957
[PubMed - indexed for MEDLINE]
4.

Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management.

Mantadakis E, Farmaki E, Buchanan GR.

J Pediatr. 2010 Apr;156(4):623-8. doi: 10.1016/j.jpeds.2009.10.015. Epub 2010 Jan 25. Review.

PMID:
20097358
[PubMed - indexed for MEDLINE]
5.

Idiopathic thrombocytopenic purpura and MMR vaccine.

Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B.

Arch Dis Child. 2001 Mar;84(3):227-9.

PMID:
11207170
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.

O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, Ball R.

Pediatrics. 2012 Feb;129(2):248-55. doi: 10.1542/peds.2011-1111. Epub 2012 Jan 9.

PMID:
22232308
[PubMed - indexed for MEDLINE]
Free Article
7.

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.

Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E.

Lancet. 1995 Mar 4;345(8949):567-9.

PMID:
7619183
[PubMed - indexed for MEDLINE]
8.

Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.

Mrozek-Budzyn D, Kiełtyka A, Majewska R.

Pediatr Infect Dis J. 2010 May;29(5):397-400. doi: 10.1097/INF.0b013e3181c40a8a.

PMID:
19952979
[PubMed - indexed for MEDLINE]
9.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

PMID:
20448530
[PubMed - indexed for MEDLINE]
Free Article
10.

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group.

N Engl J Med. 2001 Aug 30;345(9):656-61.

PMID:
11547719
[PubMed - indexed for MEDLINE]
Free Article
11.

Vaccine administration and the development of immune thrombocytopenic purpura in children.

Cecinati V, Principi N, Brescia L, Giordano P, Esposito S.

Hum Vaccin Immunother. 2013 May;9(5):1158-62. doi: 10.4161/hv.23601. Epub 2013 Jan 16. Review.

PMID:
23324619
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project.

Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, Black S, Shinefield H, Lewis E, Ward J, Marcy SM, Eriksen E, Destefano F, Chen R; Vaccine Safety Datalink Team.

Arch Pediatr Adolesc Med. 2001 Mar;155(3):354-9.

PMID:
11231801
[PubMed - indexed for MEDLINE]
13.

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.

France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R; Vaccine Safety Datalink Team.

Pediatrics. 2008 Mar;121(3):e687-92. doi: 10.1542/peds.2007-1578.

PMID:
18310189
[PubMed - indexed for MEDLINE]
Free Article
14.

Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.

Bernsen RM, van der Wouden JC.

Pediatr Allergy Immunol. 2008 Sep;19(6):544-51. doi: 10.1111/j.1399-3038.2007.00684.x. Epub 2008 Feb 7.

PMID:
18266826
[PubMed - indexed for MEDLINE]
15.

The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia.

Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N.

Vaccine. 2012 Jun 13;30(28):4292-8. doi: 10.1016/j.vaccine.2012.01.093. Epub 2012 Apr 20.

PMID:
22521285
[PubMed - indexed for MEDLINE]
16.

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark.

Andrews N, Stowe J, Miller E, Svanström H, Johansen K, Bonhoeffer J, Hviid A; VAESCO consortium.

Vaccine. 2012 Apr 19;30(19):3042-6. doi: 10.1016/j.vaccine.2011.06.009. Epub 2011 Jun 23.

PMID:
21699947
[PubMed - indexed for MEDLINE]
18.

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project.

Black S, Shinefield H, Ray P, Lewis E, Chen R, Glasser J, Hadler S, Hardy J, Rhodes P, Swint E, Davis R, Thompson R, Mullooly J, Marcy M, Vadheim C, Ward J, Rastogi S, Wise R.

Pediatr Infect Dis J. 1997 May;16(5):500-3.

PMID:
9154545
[PubMed - indexed for MEDLINE]
19.

MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis.

Vestergaard M, Hviid A, Madsen KM, Wohlfahrt J, Thorsen P, Schendel D, Melbye M, Olsen J.

JAMA. 2004 Jul 21;292(3):351-7.

PMID:
15265850
[PubMed - indexed for MEDLINE]
20.

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.

Pediatr Infect Dis J. 2005 Dec;24(12):1083-8.

PMID:
16371870
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk